Previous Article | Next Article ![]()
Infection and Immunity, October 2001, p. 6179-6185, Vol. 69, No. 10
Department of Microbiology and the Institute
for Cellular and Molecular Biology, University of Texas, Austin,
Texas 78712,1 and Department of Medical
Microbiology and Immunology, University of Wisconsin
Received 24 April 2001/Returned for modification 18 June
2001/Accepted 11 July 2001
The uropathogenic Escherichia coli strain
CFT073 has multiple iron acquisition systems, including heme
and siderophore transporters. A tonB mutant derivative
of CFT073 failed to use heme as an iron source or to utilize the
siderophores enterobactin and aerobactin, indicating that transport of
these compounds in CFT073 is TonB dependent. The TonB The virulence of pathogenic
Escherichia coli is dependent upon the ability to multiply
in host tissues (14). Iron is an essential nutrient for
growth of E. coli, but the availability of this element
within the host is limited. The bulk of the iron in humans is
intracellular, predominately found in heme proteins or sequestered in
ferritin, while the smaller amount of extracellular iron is tightly
bound to high-affinity iron-binding proteins (30, 39).
Pathogenic E. coli bacteria have evolved a variety of
mechanisms to acquire iron from host sources (14). One
mechanism is the synthesis and transport of siderophores,
low-molecular-weight iron chelators with a high affinity for iron
(8). Most E. coli strains, and other enteric
bacteria, produce the catechol siderophore enterobactin
(11). Additionally, aerobactin, a hydroxamate
siderophore, is produced by many E. coli strains isolated
from patients with urinary tract infection (UTI), bacteremia, or other
extraintestinal infections (22). The precise contribution
to virulence of either aerobactin or enterobactin is
not well established (14). Another mechanism for iron
acquisition in pathogenic E. coli is the direct utilization
of host iron compounds, particularly heme or hemoglobin (25,
26). We showed previously that a chromosomal locus encoding heme
utilization genes is widely distributed among pathogenic E. coli and Shigella dysenteriae strains (32, 51,
55).
Transport of iron associated with siderophores or heme requires
specific outer membrane receptors and depends upon TonB and its
accessory proteins, ExbB and ExbD (5, 40). The TonB
protein, which is anchored in the cytoplasmic membrane, provides energy to the outer membrane receptors for the transport of iron compounds (5). The contribution of TonB-dependent iron transport
systems in virulence has been assessed with several gram-negative
pathogens. Mutations in tonB of S. dysenteriae
(41), Salmonella enterica serovar Typhimurium
and Salmonella enterica serovar Typhi (13, 52), Vibrio cholerae (19, 45),
Pseudomonas aeruginosa (49), or
Haemophilus influenzae (21) resulted in an
avirulent phenotype in animal models. However, it is not clear whether
the loss of virulence is due to a loss of all TonB-dependent transport
systems or the loss of a particular system. With some host-pathogen
interactions it has been shown that mutations in one TonB-requiring
system attenuate the pathogen even though the pathogen possesses other iron transport systems. For example, loss of the TonB-dependent siderophore receptor in Vibrio anguillarum (8)
or the TonB-dependent hemoglobin receptors in Neisseria
meningitidis (48) and Haemophilus ducreyi
(47) was associated with a loss of virulence. In S. dysenteriae, however, the loss of virulence associated with
tonB mutation was not reproduced by mutations affecting
siderophore biosynthesis and heme uptake systems (41),
indicating that there are other TonB-dependent systems that are
required for virulence in Shigella.
This study was undertaken to identify the role of TonB and the
TonB-dependent iron uptake systems in uropathogenic E. coli (UPEC) using a mouse model of UTI. UTI is the most common
form of extraintestinal infection due to E. coli
(14), and E. coli is one of the most common
causative agents of all types of UTIs (22). A variety of
virulence factors contributing to uropathogenesis of E. coli
have been recognized, including specific fimbriae, hemolysin
production, presence of colicin V plasmids, certain capsular and
lipopolysaccharide antigens (22), and genes encoded within
a pathogenicity island (16, 17). The production of hemolysin suggests that heme utilization might be associated with uropathogenesis. However, relatively few studies have examined the
roles of iron and heme transport systems in UTIs.
Bacterial strains, plasmids, and media.
Strains and plasmids
are listed in Table 1. E. coli
was grown in LB (Luria broth) and was incubated at 37°C. When
necessary, the following antibiotics were used: chloramphenicol (Cm)
(30 µg/ml), kanamycin (Km) (50 µg/ml), and carbenicillin (Cb) (250 µg/ml). The abilities of E. coli strains to utilize
various iron sources were tested as described previously
(51). For growth in iron-restricted conditions, the iron
chelator ethylenediamine di(o-hydroxyphenylacetic acid)
(EDDA) (Sigma Chemical Co.) was added at a concentration of 1 mg/ml.
The hemin (Sigma) concentration was 8 µM. Plasmids were introduced
into E. coli by electroporation as described by Dower et al.
(10).
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.6179-6185.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
TonB-Dependent Systems of Uropathogenic Escherichia
coli: Aerobactin and Heme Transport and TonB Are Required
for Virulence in the Mouse

Madison,
Madison, Wisconsin 537062
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
derivative showed reduced virulence in a mouse model of urinary tract
infection. Virulence was restored when the tonB gene was introduced on a plasmid. To determine the importance of the individual TonB-dependent iron transport systems during urinary tract infections, mutants defective in each of the CFT073 high-affinity iron
transport systems were constructed and tested in the mouse model.
Mouse virulence assays indicated that mutants defective in a
single iron transport system were able to infect the kidney when
inoculated as a pure culture but were unable to efficiently compete
with the wild-type strain in mixed infections. These
results indicate a role for TonB-dependent systems in the virulence of
uropathogenic E. coli strains.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Bacterial strains and plasmids used in this study
Isolation of an E. coli tonB mutant. A spontaneous tonB mutant of CFT073 was obtained by screening colonies resistant to a 1-mg/ml concentration of Pirazmonam (S. J. Lucania, Bristol-Myers Squibb Co.) for loss of high-affinity iron transport as described previously (24, 51).
Construction of isogenic iron transport system mutants by allelic
exchange.
The chuA, entF, iucB, and iutA
mutants of CFT073 were generated by allelic exchange. The genes were
PCR amplified as described below and cloned into pBluescript SK
(Stratagene). An antibiotic resistance cassette was inserted into the
gene, which was then subcloned into the indicated vector. Each of the
following constructs was introduced into CFT073 by electroporation or,
for plasmid pCVD442 constructs, by conjugation using the donor strain
SM10 (
pir). Putative mutants were screened for the appropriate
resistance patterns, for loss of the plasmid, for the presence of the
interrupted gene in the chromosome by PCR, and for the correct phenotype.
Mouse virulence assays. A modification of the mouse model of ascending UTI originally described by Hagberg et al. (18) was used for this study. Swiss-Webster mice were used as the test animals. Cultures of CFT073 and their isogenic mutants were prepared by picking single colonies from plates and inoculating 40 ml of LB in a 500-ml flask. These cultures were grown at 37°C without agitation for 2 days. The cultures were then diluted to an A600 of 0.8, 40 ml of the culture was centrifuged, and the pellet was resuspended in 0.250 ml of phosphate-buffered saline. Mice were injected transurethrally in the bladders with 0.025 ml of the suspension, giving an inoculum containing approximately 109 CFU. Mice were sacrificed 2 days after challenge; bladder and kidneys were dissected and homogenized, and each was cultured on Luria (L) agar plates. Both kidneys from each mouse were combined. Viable counts were determined as CFU per gram of bladder or kidney for each mouse. Medians were calculated for all the mice used for a given set of inoculations. P values of the number of CFU per gram were calculated by the Mann-Whitney test.
For competition experiments, CBA female mice were used as the test animals. Mixed cultures of CFT073 and its isogenic mutants were grown in LB at 37°C without agitation for 2 days. The cultures were diluted and cultured another 2 days in static LB broth. Finally the strains were diluted in 40 ml of LB broth in a 500-ml flask and incubated two more days. Thirty milliliters of culture was centrifuged for 10 min at 10,000 × g, and the pellet was resuspended to an A600 of 0.6. Eighteen milliliters (each) of the wild-type and mutant strains were mixed and centrifuged for 10 min at 7,000 rpm and resuspended in 0.5 ml of phosphate-buffered saline. Mice were injected transurethrally in the bladders with 0.05 ml of the suspension. The initial inoculum was determined by plating serial dilutions of the mixed culture and replica plating on L agar containing the appropriate antibiotic. Mice were sacrificed, and samples were processed as described for the single infections; and the ratio of mutant to wild-type bacteria was determined by replica plating. The competitive index was calculated from each mouse with a positive bladder or kidney infection and is defined as the ratio of output mutant to wild-type bacteria (recovered from the bladder or kidneys) divided by the ratio of input mutant to wild-type bacteria (inoculated into the mouse). A competitive index of <1 indicates that the strain was recovered in lower numbers than the wild type. The mean competitive index was calculated for each group of mice, and P values were calculated by Student's t test. To determine whether the mutants had reverted to the wild type in vivo, bacteria recovered from the mice were plated on L agar and replica plated onto media containing antibiotics corresponding to the resistance cassette used to create the mutation. No reversion to the wild type was detected in vivo or in vitro for any of the mutants used in this study.Growth in urine. Pooled human urine was sterilized by filtration and stored at 4°C. Overnight LB cultures of CFT073 and the iron transport mutants were diluted into urine to give a cell density of approximately 107 CFU/ml and incubated at 37°C. These cultures were diluted 1:100 into urine for two more passages. Growth was monitored by plating samples on L agar to determine the number of CFU/ml of urine.
| |
RESULTS |
|---|
|
|
|---|
Identification of iron transport systems in E. coli
CFT073.
This study was undertaken to determine the role of iron
transport systems in E. coli UTI. CFT073, a UPEC strain
isolated from the blood and urine of a patient with acute
pyelonephritis, was chosen for this study, because it has been shown to
be virulent in a mouse model of ascending UTI (33, 34).
This allows us to assess the effects of iron transport system mutations
on virulence in the mouse model. We first characterized the iron
transport systems expressed by CFT073. Supernatants of iron-restricted
cultures of this strain tested positive for both catechol and
hydroxamate siderophores as determined by the Arnow assay
(1) and ferric perchlorate assay (2),
respectively. Bioassays confirmed that CFT073 synthesized and
transported the catechol enterobactin and the hydroxamate
siderophore aerobactin (Table 2).
This strain also was able to transport the fungal hydroxamate
siderophore ferrichrome and used hemin, myoglobin, hemoglobin,
heme-albumin, and hemoglobin-haptoglobin as sources of iron (Table 2
and data not shown).
|
Isolation and characterization of a CFT073 tonB mutant.
The
high-affinity iron transport systems identified in CFT073 have been
shown in other E. coli strains to require TonB for transport
of the ligand across the outer membrane (6, 11, 51).
Therefore, a TonB
derivative of CFT073 was
isolated to functionally eliminate all of these iron transport systems
and thereby determine whether any of these systems is required for
virulence in the mouse model of UTI. A tonB mutant was
isolated on medium containing Pirazmonam, an antibiotic for which
resistance in E. coli is associated with tonB
mutations (24). The putative tonB mutant,
designated CFT073-TB, was unable to use hemin or the siderophores
aerobactin, enterobactin, and ferrichrome as iron
sources, but it grew normally when iron salts were added to the medium
(Table 2 and data not shown). When CFT073-TB was transformed with
pYUK1, a plasmid containing the wild-type E. coli tonB gene,
the transport of all of these iron sources was restored (Table 2).
Restoration of wild-type function by the tonB plasmid
indicates that the mutant phenotype was likely due to a mutation in the
tonB gene and that tonB is required for the
transport of iron compounds through these uptake systems.
Virulence of the tonB mutant in the mouse model of ascending
UTI.
A mouse model of pyelonephritis was used to assess the
contribution of TonB-mediated iron uptake in the virulence of UPEC. Recovery of the tonB mutant from the kidneys of
transurethrally infected mice was compared with that of the wild-type
strain. As shown in Fig. 1 and Table 3,
bacteria were recovered from the kidneys of 78% of the mice infected
with the wild-type strain but only 20% of those inoculated with the
tonB mutant strain. None of the positive kidney cultures
from mice infected with the tonB mutant strain had more than
104 CFU/g (Fig. 1). In contrast, the median
number of bacteria recovered from mice infected with the
TonB+ complemented strain was
>104 CFU/g of kidney (Table
3). This indicates that the ability of the tonB mutant to colonize the kidney at the
inoculum tested was significantly reduced over the 48-h postinoculation
period. To confirm that the tonB mutation was responsible
for the reduced ability of the strain to infect the kidneys, the
TonB
strain complemented with the wild-type
tonB gene on a plasmid (pYUK1) was tested in the mouse model
(Fig. 1). The complemented strain was recovered from the kidneys in
numbers similar to those for the wild-type strain (Table 3). The
kidneys of 87.5% of these mice were infected, and the median number of
bacteria was >104 CFU/g of kidney.
|
|
strain was
complemented with pYUK1, the ability to compete successfully with the
wild type and infect the bladder and kidneys was restored (Table 4).
The wild-type and complemented TonB+ strains were
recovered from the bladder and kidneys of mice in similar numbers.
These data indicate that inactivation of all high-affinity iron
transport systems due to the loss of TonB significantly reduces the
infectivity and virulence of CFT073. However, it was not known whether
the reduced infectivity is due to the loss of all of these transport
systems or to the loss of one specific system.
|
Construction of isogenic mutants affecting iron uptake.
To
determine the roles of individual TonB-dependent iron transport systems
during UTIs, mutants of CFT073 defective in heme iron transport or in
siderophore-mediated iron transport were constructed, and the effects
of these mutations on virulence were tested in the mouse model. Two
aerobactin mutants, one defective in synthesis, CFT073-IUC, and
one defective in transport, CFT073-IUT, were constructed by disrupting
the iucB and iutA genes, respectively. CFT073-IUC
failed to secrete aerobactin but maintained the ability to
transport the compound (Table 2), while CFT073-IUT was able to
synthesize but not transport aerobactin (Table 2). Bioassays confirmed that the other high-affinity transport systems were functional in these mutants (Table 2). Enterobactin
synthesis mutants were constructed by allelic exchange in both
the wild-type and IucB
backgrounds (Table 2).
The entF single mutant, CFT073-ENT, and the iucB
entF double mutant, CFT073-ENT/IUC, were analyzed for iron
transport systems. These mutants were unable to produce one or both
siderophores but retained the ability to use exogenous enterobactin and aerobactin for iron transport
(Table 2).
Effects of mutations in the iron transport systems on mouse
virulence.
To define whether the synthesis and transport of
siderophores or the expression of the heme receptor was involved in
virulence, the wild-type CFT073 strain and the isogenic iron
utilization mutants were compared using the mouse model. The
single siderophore synthesis mutants, CFT073-IUC and CFT073-ENT,
and the heme transport mutant, CFT073-LH, infected both the kidney
(Table 5) and bladder (data not shown).
The mutants were able to infect the kidneys of the majority of the
mice, and the numbers of bacteria isolated from the kidneys were
similar to that for the wild type (P > 0.5) (Table 5).
These data suggest that the synthesis of either of the siderophores,
perhaps in conjunction with the heme uptake system, provides
sufficient iron for the multiplication of the E. coli bacteria in the bladders and kidneys.
|
Iuc
mutant strain
(Table 5) (P = 0.02). The fact that the double mutant
showed a reduced ability to invade or colonize the mouse kidney
suggests that siderophores are required for growth in this environment
(Table 5). If this hypothesis is correct, then it should be possible to
rescue the siderophore synthesis mutant by coinfection with a wild-type
strain that is secreting the siderophores. Mice were infected with a
mixed culture containing the wild-type strain and the double-mutant
strain, and in this competition assay, the double mutant was able to
survive and colonize the bladders and the kidneys of mice (Table
6). The numbers of
Ent
Iuc
bacteria were
equal to the numbers of the wild-type bacteria in the mixed infection
(Table 6), suggesting that the exogenous siderophores synthesized by
the wild-type strain are sufficient to suppress the effect of the
mutations.
|
mutant strain was severely reduced in its
ability to compete with the wild type for colonization of the bladders
of infected mice. In the kidneys, the IutA
mutant was unable to colonize in competition with the wild-type strain,
and none of the iutA mutant bacteria were recovered from any
of the kidneys.
Similarly, CFT073-LH, the heme receptor mutant of
CFT073, showed a disadvantage when compared with the
wild-type strain in the competition assay for the ability to
colonize the bladder and kidneys of mice (Table 6). The
ChuA
strain was recovered from bladders and
kidneys of only three of the seven infected mice, and the competitive
indices indicated that this strain was significantly diminished in its
ability to colonize and grow in these organs (Table 6).
Growth of iron transport mutants in urine. To determine whether urine represents an iron-restricted environment and could influence the need for one or more iron transport systems in the human urinary tract, we measured growth of the strains in human urine in vitro. All the strains tested had similar growth rates and reached approximately the same final density in the first passage in urine (A650 = 0.5 to 0.6). The strains were subcultured in urine in case a growth defect of the mutants due to iron limitation was suppressed by iron storage during growth in broth prior to the initial inoculation into urine. The mutants and the wild-type strain had equivalent growth rates and reached the same final density (A650 = 0.5 to 0.6) following the second and third passage in urine. Thus, urine does not appear to be an iron-limiting environment for growth of an E. coli UTI strain.
| |
DISCUSSION |
|---|
|
|
|---|
This study examined the role of TonB and TonB-mediated iron uptake systems in the ability of UPEC to infect the urinary tract of the mouse. TonB is known to be required by E. coli for high-affinity transport and utilization of several nutrients including chelated iron and vitamin B12 (3, 11, 35). The fact that the tonB mutant of the UPEC strain CFT073 was attenuated for infection of the bladder and kidney indicates that CFT073 requires TonB in vivo, most likely to mediate the uptake of iron during colonization and multiplication within the urinary tract.
A contribution of tonB in host colonization and virulence has been shown for other pathogens, such as Salmonella serovar Typhimurium (52), H. influenzae (21) and S. dysenteriae (41). Tsolis et al. (52) showed that a tonB mutant of Salmonella enterica serovar Typhimurium was attenuated for infection in mice. They proposed that TonB-mediated iron uptake in Salmonella serovar Typhimurium was required for colonization of extraintestinal tissues (52). In S. dysenteriae, TonB is required for growth in the intracellular environment of host cells; a tonB mutant retained its ability to invade host cells but failed to multiply intracellularly and did not spread to adjacent cells (41). These studies, however, do not indicate which TonB-dependent systems are required in the various stages of infections.
To determine the relative contributions of individual TonB-dependent iron transport systems in UPEC, mutants of CFT073 defective in each of the characterized high-affinity iron transporters were analyzed in a mouse model of UTI. When administered as pure cultures, the mutants with defects in enterobactin or aerobactin were still able to infect the bladder and kidney. This suggests that production of either siderophore is sufficient to allow acquisition of iron in the urinary tract. This is in agreement with previous studies by Montgomerie et al. (36) and Miles and Khimji (31) showing that neither aerobactin nor enterobactin production correlated with an enhanced ability to cause UTI. Synthesis of at least one siderophore appears to be required in vivo; a mutant unable to produce either of the siderophores showed reduced infection of the mouse kidney. The ability of a siderophore-producing wild-type strain to compensate for the attenuation of the double siderophore synthesis mutant in the competition assay indicates that siderophores are synthesized and secreted in vivo and promote colonization.
While a single siderophore-mediated iron transport system may be sufficient for colonization, it seemed likely that the presence of additional systems could improve efficiency of growth in the host by allowing the pathogen to take advantage of multiple iron sources. The two different types of siderophores produced by CFT073 may function in different environments within the host or at different times during the course of an infection. Brock et al. (7) have presented evidence suggesting that enterobactin and aerobactin fulfill somewhat different roles in that they may acquire iron in vivo from different sources: enterobactin by scavenging predominantly extracellular, transferrin-bound iron and aerobactin by obtaining iron preferentially from host intracellular iron complexes. Heme is the most abundant iron source in vivo, and the presence of a heme transport system in CFT073 may be important for the acquisition of iron from heme or hemoglobin. Recent evidence in support for the role of the chu heme transport system in virulence of extraintestinal E. coli strains was presented by Bonacorsi et al. (4). The authors identified the chu locus as one of the specific chromosomal regions associated with the ability of E. coli K1 strains to invade the meninges of neonates. Although utilization of heme may not be essential for the initial colonization of the bladder by UPEC strains, it could play a role in the later stages of disease when there is hemolysis of host cells and release of heme and hemoglobin. Many of the UPEC strains, including CFT073, produce one or more hemolysins (12, 23), and expression of hemolysin (15), like the heme transport system (51), is increased under conditions of iron starvation. Furthermore, it has been recently shown that ChuA expression is influenced by RfaH in the UPEC strain 536 (37). RfaH is a positive effector of transcription of hemolysin, as well as lipopolysaccharide biosynthetic genes (27, 28). Thus, the hemolysin and heme transport systems may work in concert to take advantage of the abundant supply of heme as an iron source within the host.
The potential benefit to the uropathogen of having heme and aerobactin iron transport systems, in addition to enterobactin, was assessed by measuring direct competition between the heme or aerobactin mutants and wild-type bacteria. Under these conditions, the mutants were found to be at a severe disadvantage compared to the wild type. The presence of multiple iron transport systems allows the wild-type strain to grow more rapidly in vivo and outcompete the strains lacking heme or aerobactin-mediated iron transport. This most likely reflects growth in the tissues of the urinary tract rather than in urine, since none of the mutants showed any reduction in the growth rate relative to the wild type in human urine in vitro.
It is likely that there are additional TonB-dependent iron transport systems in pathogenic E. coli that contribute to iron acquisition in vivo. A potential iron transport system was found by DNA sequence analysis of a pathogenicity island of CFT073 (17). Two open reading frames (L5 and R4) within the island showed homology to TonB-dependent outer membrane receptors. Further characterization is required to determine whether either of these open reading frames, or other unidentified iron transport systems, plays a role in iron transport by UPEC and contributes to the loss of infectivity associated with the tonB mutation. While the loss of any one of these iron transporters may reduce the fitness of the pathogen in vivo, the redundancy in iron transport systems may partially compensate for the loss of one or more systems. The severe defect associated with the tonB mutation likely reflects the loss of all of these systems, although it is possible that TonB also may be required in vivo for a function other than iron transport.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants AI16935 to S.M.P., AI39000 to R.A.W., and AI01583 to P.R. from the National Institutes of Health. A.G.T. was supported by a research supplement for underrepresented minorities from the National Institute of Allergy and Infectious Diseases and by a David and Lucile Packard Foundation Fellowship from the National Hispanic Scholarship Fund.
We thank the Bristol-Myers Squibb Company for generously providing Pirazmonam. We thank Yuki Gleason and Ana-Maria Valle for construction of the tonB plasmid and expert technical assistance and Elizabeth Wyckoff and Stephanie Reeves for critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and the Institute for Cellular and Molecular Biology, University of Texas, Austin, TX 78712. Phone: (512) 471-5204. Fax: (512) 471-7088. E-mail: payne{at}mail.utexas.edu.
Present address: Center for Vaccine Development and Department of
Microbiology and Immunology, University of Maryland School of Medicine,
Baltimore, MD 21201.
Editor: A. D. O'Brien
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Arnow, L. E.
1937.
Colorimetric determination of the components of 3,4-dihydroxyphenylalanine-tyrosine mixtures.
J. Biol. Chem.
118:531-537 |
| 2. |
Atkin, C. L.,
J. B. Neilands, and H. J. Phaff.
1970.
Rhodotorulic acid from species of Leucosporidium, Rhodosporidium, Rhodotorula, Sporidiobolus, and Sporobolomyces, and a new alanine-containing ferrichrome from Cryptococcus melibiosum.
J. Bacteriol.
103:722-733 |
| 3. |
Bassford, P. J., Jr.,
C. Bradbeer,
R. J. Kadner, and C. A. Schnaitman.
1976.
Transport of vitamin B12 in tonB mutants of Escherichia coli.
J. Bacteriol.
128:242-247 |
| 4. |
Bonacorsi, S. P. P.,
O. Clermont,
C. Tinsley,
I. LeGall,
J. C. Beaudoin,
J. Elion,
X. Nassif, and E. Bingen.
2000.
Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains.
Infect. Immun.
68:2096-2101 |
| 5. | Braun, V. 1995. Energy-coupled transport and signal transduction through the gram-negative outer membrane via TonB-ExbB-ExbD-dependent receptor proteins. FEMS Microbiol. Rev. 16:295-307[CrossRef][Medline]. |
| 6. | Braun, V., K. Hantke, and W. Köster. 1998. Bacterial iron transport: mechanisms, genetics, and regulation. In A. Sigel, and H. Sigel (ed.), Metal ions in biological systems. Iron transport and storage in microorganisms, plants and animals. Marcel Dekker, New York, N.Y. |
| 7. |
Brock, J. H.,
P. H. Williams,
J. Licéaga, and K. G. Woodridge.
1991.
Relative availability of transferrin-bound iron and cell-derived iron to aerobactin-producing and enterochelin-producing strains of Escherichia coli and to other microorganisms.
Infect. Immun.
59:3185-3190 |
| 8. |
Crosa, J. H.
1989.
Genetics and molecular biology of siderophore-mediated iron transport in bacteria.
Microbiol. Rev.
53:517-530 |
| 9. |
Donnenberg, M. S., and J. B. Kaper.
1991.
Construction of a eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector.
Infect. Immun.
59:4310-4317 |
| 10. |
Dower, W. J.,
J. F. Miller, and C. W. Ragsdale.
1988.
High efficiency transformation of E. coli by high voltage electroporation.
Nucleic Acids Res.
16:6127-6145 |
| 11. | Earhart, C. F. 1996. Uptake and metabolism of iron and molybdenum, p. 1075-1090. In F. C. Neidhardt (ed.), Escherichia coli and Salmonella. ASM Press, Washington, D.C. |
| 12. |
Felmlee, T.,
S. Pellett, and R. A. Welch.
1985.
Nucleotide sequence of an Escherichia coli chromosomal hemolysin.
J. Bacteriol.
163:94-105 |
| 13. | Gorbacheva, V. Y., G. Faundez, H. P. Godfrey, and F. C. Cabello. 2001. Restricted growth of ent(-) and tonB mutants of Salmonella enterica serovar Typhi in human Mono Mac 6 monocytic cells. FEMS Microbiol. Lett. 196:7-11[Medline]. |
| 14. | Griffiths, E. 1997. Iron and the virulence of Escherichia coli, p. 331-371. In M. Sussman (ed.), Escherichia coli mechanisms of virulence. Cambridge University Press, Cambridge, United Kingdom. |
| 15. | Gruenig, H. M., D. Rutschi, C. Schoch, and G. Lebek. 1987. The chromosomal fur gene regulates the extracellular haemolytic activity encoded by certain Hly plasmids. Zentbl. Bakteriol. Hyg. A 266:231-238. |
| 16. | Guyer, D. M., I. R. Henderson, J. P. Nataro, and H. L. Mobley. 2000. Identification of Sat, an autotransporter toxin produced by uropathogenic Escherichia coli. Mol. Microbiol. 38:53-66[CrossRef][Medline]. |
| 17. |
Guyer, D. M.,
J.-S. Kao, and H. L. Mobley.
1998.
Genetic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and catheter-associated bacteriuria and from fecal samples.
Infect. Immun.
66:4411-4417 |
| 18. |
Hagberg, L.,
I. Engberg,
R. Freter,
J. Lam,
S. Olling, and E. C. Svanborg.
1983.
Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.
Infect. Immun.
40:273-283 |
| 19. |
Henderson, D. P., and S. M. Payne.
1994.
Vibrio cholerae iron transport systems: roles of heme and siderophore iron transport in virulence and identification of a gene associated with multiple iron transport systems.
Infect. Immun.
62:5120-5125 |
| 20. | Hong, M., and S. M. Payne. 1997. Effect of mutations in Shigella flexneri chromosomal and plasmid-encoded lipopolysaccharide genes on invasion and serum resistance. Mol. Microbiol. 24:779-791[CrossRef][Medline]. |
| 21. |
Jarosik, G. P.,
J. D. Sanders,
L. D. Cope,
U. Muller-Eberhard, and E. J. Hansen.
1994.
A functional tonB gene is required for both utilization of heme and virulence expression by Haemophilus influenzae type b.
Infect. Immun.
62:2470-2477 |
| 22. |
Johnson, J. R.
1991.
Virulence factors in Escherichia coli urinary tract infection.
Clin. Microbiol. Rev.
4:80-128 |
| 23. |
Kao, J.-S.,
D. M. Stucker,
J. W. Warren, and H. L. T. Mobley.
1997.
Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains.
Infect. Immun.
65:2812-2820 |
| 24. | Larsen, R. A., M. G. Thomas, G. E. Wood, and K. Postle. 1994. Partial suppression of an Escherichia coli TonB transmembrane domain mutation (delta V17) by a missense mutation in ExbB. Mol. Microbiol. 13:627-640[CrossRef][Medline]. |
| 25. |
Law, D., and J. Kelly.
1995.
Use of heme and hemoglobin by Escherichia coli O157 and other Shiga-like-toxin-producing E. coli serogroups.
Infect. Immun.
63:700-702 |
| 26. |
Law, D.,
K. M. Wilkie,
R. Freeman, and F. K. Gould.
1992.
The iron uptake mechanisms of enteropathogenic Escherichia coli: the use of haem and haemoglobin during growth in an iron-limited environment.
J. Med. Microbiol.
37:15-21 |
| 27. |
Leeds, J. A., and R. A. Welch.
1997.
Enhancing transcription through the Escherichia coli hemolysin operon, hlyCABD: RfaH and upstream JUMPStart DNA sequences function together via a postinitiation mechanism.
J. Bacteriol.
179:3519-3527 |
| 28. |
Leeds, J. A., and R. A. Welch.
1996.
RfaH enhances elongation of Escherichia coli hlyCABD mRNA.
J. Bacteriol.
178:1850-1857 |
| 29. | Martinez, J. L., M. Herrero, and V. de Lorenzo. 1994. The organization of intercistronic regions of the aerobactin operon of pColV-K30 may account for the differential expression of the iucABCD iutA genes. J. Mol. Biol. 238:288-293[CrossRef][Medline]. |
| 30. | Mietzner, T. A., and S. A. Morse. 1994. The role of iron-binding proteins in the survival of pathogenic bacteria. Annu. Rev. Nutr. 14:471-493[CrossRef][Medline]. |
| 31. |
Miles, A. A., and P. L. Khimji.
1975.
Enterobacterial chelators of iron: their occurrence, detection, and relation to pathogenicity.
J. Med. Microbiol.
8:477-490 |
| 32. |
Mills, M., and S. M. Payne.
1995.
Genetics and regulation of heme iron transport in Shigella dysenteriae and detection of an analogous system in Escherichia coli O157:H7.
J. Bacteriol.
177:3004-3009 |
| 33. |
Mobley, H. L.,
D. M. Green,
A. L. Trifillis,
D. E. Johnson,
G. R. Chippendale,
C. V. Lockatell,
B. D. Jones, and J. W. Warren.
1990.
Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.
Infect. Immun.
58:1281-1289 |
| 34. | Mobley, H. L., K. G. Jarvis, J. P. Elwood, D. I. Whittle, C. V. Lockatell, R. G. Russell, D. E. Johnson, M. S. Donnenberg, and J. W. Warren. 1993. Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain. Mol. Microbiol. 10:143-155[Medline]. |
| 35. | Moeck, G. S., and J. W. Coulton. 1998. TonB-dependent iron acquisition: mechanism of siderophore-mediated active transport. Mol. Microbiol. 28:675-681[CrossRef][Medline]. |
| 36. |
Montgomerie, J. Z.,
A. Bindereif,
J. B. Neilands,
G. M. Kalmanson, and L. B. Guze.
1984.
Association of hydroxamate siderophore (aerobactin) with Escherichia coli isolated from patients with bacteremia.
Infect. Immun.
46:835-838 |
| 37. |
Nagy, G.,
U. Dobrindt,
M. Kupfer,
L. Emody,
H. Karch, and J. Hacker.
2001.
Expression of hemin receptor molecule ChuA is influenced by RfaH in uropathogenic Escherichia coli strain 536.
Infect. Immun.
69:1924-1928 |
| 38. | Occhino, D. A., E. E. Wyckoff, D. P. Henderson, T. J. Wrona, and S. M. Payne. 1998. Vibrio cholerae iron transport: haem transport genes are linked to one of two sets of tonB, exbB, exbD genes. Mol. Microbiol. 29:1493-1507[CrossRef][Medline]. |
| 39. | Otto, B. R., A. M. J. J. Verweij-van, and D. M. MacLaren. 1992. Transferrins and heme-compounds as iron sources for pathogenic bacteria. Crit. Rev. Microbiol. 18:217-233[Medline]. |
| 40. | Postle, K. 1993. TonB protein and energy transduction between membranes. J. Bioenerg. Biomembr. 25:591-601[Medline]. |
| 41. |
Reeves, S. A.,
A. G. Torres, and S. M. Payne.
2000.
TonB is required for intracellular growth and virulence of Shigella dysenteriae.
Infect. Immun.
68:6329-6336 |
| 42. |
Runyen-Janecky, L. J.,
M. Hong, and S. M. Payne.
1999.
The virulence plasmid-encoded impCAB operon enhances survival and induced mutagenesis in Shigella flexneri after exposure to UV radiation.
Infect. Immun.
67:1415-1423 |
| 43. | Rusnak, F., M. Sakaitani, D. Drueckhammer, J. Reichert, and C. T. Walsh. 1991. Biosynthesis of the Escherichia coli siderophore enterobactin: sequence of the entF gene expression and purification of EntF, and analysis of covalent phosphopantetheine. Biochemistry 30:2916-2927[CrossRef][Medline]. |
| 44. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 45. | Seliger, S., A. Mey, A. Valle, and S. Payne. 2001. The two TonB systems of Vibrio cholerae: redundant and specific functions. Mol. Microbiol. 39:801-812[CrossRef][Medline]. |
| 46. | Simon, R., U. Priefer, and A. Pühler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Bio/Technology 1:784-791[CrossRef]. |
| 47. |
Stevens, M. K.,
S. Porcella,
J. Klesney-Tait,
S. Lumbley,
S. E. Thomas,
M. V. Norgard,
J. D. Radolf, and E. J. Hansen.
1996.
A hemoglobin-binding outer membrane protein is involved in virulence expression by Haemophilus ducreyi in an animal model.
Infect. Immun.
64:1724-1735 |
| 48. | Stojiljkovic, I., V. Hwa, L. de Saint Martin, P. O'Gaora, X. Nassif, F. Heffron, and M. So. 1995. The Neisseria meningitidis haemoglobin receptor: its role in iron utilization and virulence. Mol. Microbiol. 15:531-541[Medline]. |
| 49. |
Takase, H.,
H. Nitanai,
K. Hoshino, and T. Otani.
2000.
Requirement of the Pseudomonas aeruginosa tonB gene for high-affinity iron acquisition and infection.
Infect. Immun.
68:4498-4504 |
| 50. | Torres, A. G. 1999. Ph.D. dissertation. The University of Texas at Austin, Austin. |
| 51. | Torres, A. G., and S. M. Payne. 1997. Haem iron-transport system in enterohaemorrhagic Escherichia coli O157:H7. Mol. Microbiol. 23:825-833[CrossRef][Medline]. |
| 52. |
Tsolis, R. M.,
A. J. Baumler,
F. Heffron, and I. Stojiljkovic.
1996.
Contribution of TonB- and Feo-mediated iron uptake to growth of Salmonella typhimurium in the mouse.
Infect. Immun.
64:4549-4556 |
| 53. | Wang, R. F., and S. R. Kushner. 1991. Construction of versatile low-copy number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene 100:195-199[CrossRef][Medline]. |
| 54. |
Williams, P. H.
1979.
Novel iron uptake system specified by ColV plasmids: an important component in the virulence of invasive strains of Escherichia coli.
Infect. Immun.
26:925-932 |
| 55. | Wyckoff, E. E., D. Duncan, A. G. Torres, M. Mills, K. Maase, and S. M. Payne. 1998. Structure of the Shigella dysenteriae haem transport locus and its phylogenetic distribution in enteric bacteria. Mol. Microbiol. 28:1139-1152[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»